Mirakel
Product Images NDC 78589-100

10 FDA label images from Sanvio, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Mirakel (NDC 78589-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanvio, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Active Ingredients (Active Ingredients)

Active Ingredients (Active Ingredients)
A drug facts panel section listing active ingredients and their purposes: Benzocaine 10% as an external analgesic and Resorcinol 1.50% also as an external analgesic.*
FDA Label Image

Directions (Directions)

Directions (Directions)
Directions text panel for mirakel by Sanvio, Inc. It provides application instructions for adults and children 12 years and older to apply a small amount to the affected area 3-4 times daily, and advises consulting a doctor for children under 12 years of age.*
FDA Label Image

Inactive Ingredients (Inactive Ingredients)

Inactive Ingredients (Inactive Ingredients)
The image shows a list of inactive ingredients for the product mirakel by Sanvio, Inc. Ingredients include aloe barbadensis (aloe vera) leaf extract, butylated hydroxytoluene, carbomer, cetyl alcohol, cholecalciferol, edetate disodium, glyceryl monostearate, isopropyl palmitate, maltodextrin, mentha piperita (peppermint) oil, methylparaben, mineral oil, PEG-40 hydrogenated castor oil, PEG-100 stearate, petrolatum, propylene glycol, propyl-paraben, purified water, retinyl palmitate, sodium lauryl sulfate, thymus vulgaris (thyme) flower leaf oil, tocopheryl acetate, triethanolamine, and xanthan gum.*
FDA Label Image

Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)

Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)
A drug safety warning panel stating: 'Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.' This panel provides important emergency instructions related to the product mirakel by Sanvio, Inc.*
FDA Label Image

Other Information (Other Information)

Other Information (Other Information)
A drug information panel titled 'Other Information' listing storage instructions to store at 20-25°C (68-77°F), a caution that skin is more sensitive to sunlight when using the product, and advice to keep the container tightly closed after use.*
FDA Label Image

Purpose (Purpose)

Purpose (Purpose)
Drug facts panel listing active ingredients for mirakel by Sanvio, Inc., including Benzocaine 10% and Resorcinol 1.50%, both identified as external analgesics.*
FDA Label Image

Questions (Questions)

Questions (Questions)
A text panel displaying contact information for questions, including a bolded 'Questions?' followed by the phone number 1-888-855-5681, formatted in a black-bordered box with white background.*
FDA Label Image

Label Main Complete (Sanvio Mirakel Tube 30mm Gm Rod Fda 062320)

Label Main Complete (Sanvio Mirakel Tube    30mm Gm Rod Fda 062320)
mirakel cream 1 oz tube packaging label by Sanvio, Inc. The label indicates it is an advanced formula for temporary relief of pain, itching, and discomfort of minor skin irritations. It is gluten-free with a net weight of 1 oz (28 g). Active ingredients include Benzocaine 10% and Resorcinol 1.5%. The label includes a Drug Facts panel and directions for use. UPC and NDC fields are marked as TBD.*
FDA Label Image

Uses (Uses)

Uses (Uses)
A drug facts panel segment listing the uses for a product, indicating temporary relief of pain, itching, and discomfort associated with rashes, minor burns, insect bites, minor cuts, and minor skin irritations.*
FDA Label Image

Warning (Warnings)

Warning (Warnings)
Warning panel for mirakel by Sanvio, Inc. stating the product is for external use only. It advises avoiding contact with eyes and not applying over large body areas, stopping use and consulting a doctor if conditions worsen or persist beyond 7 days, and keeping the product out of reach of children with instructions to seek medical help if swallowed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.